| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.600 | None | 0.957 | 86 | 4 | 1999 | 2019 | ||||||||
|
prominin 1 | 0.410 | 0.846 | 1.9E-22 |
|
disease | 0.100 | None | 1.000 | 84 | 0 | 2006 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.967 | 83 | 1 | 1993 | 2020 | ||||||||
|
glutamic--pyruvic transaminase | 0.403 | 0.923 | 3.6E-19 |
|
disease | 0.100 | None | 0.976 | 81 | 1 | 1995 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.400 | None | 0.964 | 80 | 0 | 1996 | 2019 | ||||||||
|
EPH receptor B2 | 0.374 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 78 | 0 | 2004 | 2020 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.100 | None | 0.987 | 78 | 0 | 2007 | 2020 | |||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.600 | None | 0.977 | 77 | 4 | 1998 | 2019 | ||||||||
|
epithelial cell adhesion molecule | 0.451 | 0.885 | 1.3E-07 |
|
disease | 0.200 | None | 0.986 | 73 | 2 | 2008 | 2020 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.700 | None | 0.987 | 70 | 0 | 1989 | 2020 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.100 | None | 0.973 | 70 | 1 | 2002 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.600 | None | 1.000 | 69 | 0 | 1985 | 2020 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.970 | 67 | 0 | 2004 | 2020 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.400 | None | 0.985 | 65 | 3 | 1985 | 2019 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 65 | 3 | 2007 | 2020 | ||||||||
|
DNL-type zinc finger | 0.663 | 0.538 | 2.5E-04 |
|
disease | 0.100 | None | 0.984 | 64 | 0 | 1991 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 1.000 | None | 0.969 | 60 | 1 | 1994 | 2020 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.300 | None | 1.000 | 59 | 1 | 2000 | 2020 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
disease | 0.400 | None | 0.967 | 58 | 0 | 2002 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.983 | 55 | 0 | 2007 | 2020 | ||||||||
|
heparan sulfate proteoglycan 2 | 0.438 | 0.885 | 1.0E-19 |
|
disease | 0.100 | None | 1.000 | 55 | 0 | 1982 | 2019 | ||||||||
|
vimentin | 0.372 | 0.846 | 0.71 |
|
disease | 0.100 | None | 0.982 | 55 | 0 | 2004 | 2019 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 53 | 2 | 1994 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.500 | None | 0.981 | 53 | 0 | 2004 | 2020 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.400 | None | 0.962 | 52 | 0 | 1989 | 2019 |